Equine pituitary pars intermedia dysfunction: current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group

The purpose of this article is to provide a review of the current knowledge and opinions about the epidemiology, clinical findings (including sequelae), diagnosis, treatment and monitoring of equine pituitary pars intermedia dysfunction, particularly in the Australian context. This information and the recommendations provided will assist practitioners in making informed decisions regarding the diagnosis and management of this disorder.     

Pharmacokinetic profiles of the two major active metabolites of metamizole (dipyrone) in cats following three different routes of administration

This study was performed to determine pharmacokinetic profiles of the two active metabolites of the analgesic drug metamizole (dipyrone , MET), 4‐methylaminoantipyrine (MAA), and 4‐aminoantipyrine (AA), after intravenous (i.v., intramuscular (i.m.), and oral (p.o.) administration in cats. Six healthy mixed‐breed cats were administered MET (25 mg/kg) by i.v., i.m., or p.o. routes in a crossover design. Adverse clinical signs, namely salivation and vomiting, were detected in all groups (i.v. 67%, i.m. 34%, and p.o. 15%). The mean maximal plasma concentration of MAA for i.v., i.m., and p.o. administrations was 148.63 ± 106.64, 18.74 ± 4.97, and 20.59 ± 15.29 μg/ml, respectively, with about 7 hr of half‐life in all routes. Among the administration routes, the area under the plasma concentration curve (AUC) value was the lowest after i.m. administration and the AUC_EV/i.v. ratio was higher in p.o. than the i.m. administration without statistical significance. The plasma concentration of AA was detectable up to 24 hr, and the mean plasma concentrations were smaller than MAA. The present results suggest that MET is converted into the active metabolites in cats as in humans. Further pharmacodynamics and safety studies should be performed before any clinical use.     

Proton accumulation accelerated by heavy chemical nitrogen fertilization and its long-term impact on acidifying rate in a typical arable soil in the Huang-Huai-Hai Plain

Cropland productivity has been signiifcantly impacted by soil acidiifcation resulted from nitrogen (N) fertilization, especialy as a result of excess ammoniacal N input. With decades’ intensive agricul...     

西吉县农用地膜应用污染现状及对策

本文就西吉县农用地膜的应用现状和污染现状进行了分析,并就这一现状提出了促进旱作农业可持续发展的对策措施。     

不同浓度褪黑素对氯化钠胁迫下宝岛蕉幼苗的影响

为了研究不同浓度褪黑素对宝岛蕉幼苗氯化钠胁迫的影响,使用不同浓度褪黑素处理宝岛蕉幼苗叶片,研究处理后宝岛蕉幼苗叶片和根系的可溶性糖、丙二醛、脯氨酸含量及叶质膜透性的变化。结果表明,褪黑素100μmol/L能够降低宝岛蕉幼苗叶质膜透性,提高叶片和根系可溶性糖含量,降低叶片和根系丙二醛含量,提高叶片和根系脯氨酸含量,提高幼苗耐盐性,以缓解氯化钠胁迫对宝岛蕉幼苗的伤害。     

基于NoteExpress（NE）的文献管理——从检索文献到论文写作

基于NoteExpress的文献管理功能,以日常科研论文写作为基准,从检索文献开始到利用NE的各项功能过滤筛选文献,到插入参考文献直至论文写作完成、发表等方面,来说明怎样利用NE的检索、管理、写作功能来科学管理文献,提高写作效率。     

白藜芦醇和褪黑素对绵羊胎儿成纤维细胞转染及卵母细胞体外成熟的影响

试验旨在利用白藜芦醇(Re)和褪黑素(MT)提高绵羊胎儿成纤维细胞电穿孔转染(电转)效率、优化卵母细胞体外成熟体系,以提高转基因动物生产效率。将绵羊胎儿成纤维细胞分为6组:对照组、添加白藜芦醇高、中、低(R^-5、R^-6、R^-7)3种浓度组及白藜芦醇和褪黑素联合添加组(R^-5M^-5、R^-6M^-7),通过电转效率和细胞凋亡情况确定电转体系优化方案;通过对细胞周期、线粒体膜电位及活性氧(ROS)的检测研究其作用机制。将绵羊卵母细胞分为对照组及白藜芦醇和褪黑素(R^-5M^-5、R^-6M^-7)联合添加组,通过绵羊卵母细胞体外成熟后卵丘细胞扩展、第一极体排出及体外受精胚胎的卵裂率检测其对卵母细胞体外成熟的作用。研究结果显示,分离的绵羊胎儿成纤维细胞P3代增殖旺盛,细胞生长曲线呈典型的S型;与对照组相比,所有试验组胎儿成纤维细胞的电转效率均显著提高(P<0.05),R^-5M^-5组电转效率最高;R^-6M^-7组显著降低细胞凋亡率(P<0.05),R^-5、R^-6、R^-5M^-5和R^-6M^-7组均显著促进细胞增殖(P<0.05);R^-6、R^-7、R^-5M^-5和R^-6M^-7组G1期细胞增加,S期细胞相对减少,但差异均不显著(P>0.05);R^-6、R^-7、R^-5M^-5和R^-6M^-7组成纤维细胞内ROS水平均显著降低(P<0.05),R^-6、R^-5M^-5和R^-6M^-7组线粒体膜电位均显著增加(P<0.05);R^-6M^-7组显著促进绵羊卵丘细胞扩展、提高卵母细胞第一极体排出率和体外受精胚胎发育能力(P<0.05)。综上,白藜芦醇和褪黑素可以优化绵羊胎儿成纤维细胞电转体系,提高卵母细胞体外成熟效率,为白藜芦醇和褪黑素在转基因动物生产中的应用提供参考依据。     

绿原酸提取物的抗氧化活性协同增效作用

以蒲公英和葵花籽粕绿原酸提取物为试材,采用FRAP亚铁离子还原能力为考察指标,研究了蒲公英和葵花籽粕来源的绿原酸提取物对抗氧化活性的影响因素,以抗氧化活性的半抑制浓度IC50为复配依据,评价蒲公英绿原酸与葵花籽粕复配品的抗氧化协同增效作用,以期为开发绿色高效的天然抗氧化剂提供参考依据.结果表明:反应体系在pH为4.0、37℃条件下,蒲公英和葵花籽粕绿原酸对FRAP亚铁离子还原能力达到最高,分别为1.11、1.09.蒲公英绿原酸可提高葵花籽粕复配品对FRAP亚铁离子的还原能力,具有抗氧化协同增效作用.